No description available.

Protein synthesis is a process by which organisms manufacture their proteins that perform various cellular activities either alone or in combination with other similar or different molecules. In eubacteria, protein synthesis proceeds at a rate of around 15 amino acids per second. The ribosomes, charged tRNAs and mRNAs can be considered as the core components of protein synthesis system which, in addition, involves a panel of non-ribosomal proteins that regulate the speed, specificity and accuracy of the process. Peptidyl-tRNA hydrolase (Pth) and ribosome recycling factor (RRF) are two such non-ribosomal proteins involved in protein synthesis. These two proteins are essential for eubacterial survival and the work reported in this thesis involves structural characterization of these two proteins from the bacterial pathogen, Mycobacterium tuberculosis. The protein structures were solved using established techniques of protein crystallography. Hanging drop vapour diffusion method and crystallization under oil using microbatch plates were the methods employed for protein crystallization. X-ray intensity data were collected on a MAR Research imaging plate mounted on a Rigaku RU200 X-ray generator in all the cases. The data were processed using DENZO and MOSFLM. The structures were solved by molecular replacement method using the program PHASER. Structure refinements were carried out using programs CNS and REFMAC. Model building was carried out using COOT. PROCHECK, ALIGN, CHIMERA, and PYMOL were used for structure validation and analysis of the refined structures. Peptidyl-tRNA hydrolase cleaves the ester bond between tRNA and the attached peptide in peptidyl-tRNA that has dropped off from ribosome before reaching the stop codon, in order to avoid the toxicity resulting from peptidyl-tRNA accumulation and to free the tRNA to make it available for further rounds in protein synthesis. To begin with, the structure of the enzyme from M. tuberculosis (MtPth) was determined in three crystal forms. This structure and the structure of the same enzyme from Escherichia coli (EcPth) in its crystal differ substantially on account of the binding of the C-terminus of the E.coli enzyme to the peptide binding site of a neighboring molecule in the crystal. A detailed examination of this difference led to an elucidation of the plasticity of the binding site of the enzyme. The peptide-binding site of the enzyme is a cleft between the body of the molecule and a polypeptide stretch involving a loop and a helix. This stretch is in open conformation when the enzyme is in the free state as in the crystals of MtPth. Furthermore, there is no physical continuity between the tRNA and the peptide-binding sites. The molecule in the EcPth crystal mimics the peptide-bound conformation of the enzyme. The peptide stretch involving a loop and a helix, referred to earlier, now closes on the bound peptide. Concurrently, a gate connecting the tRNA and the peptide-binding site opens primarily through the concerted movement of the two residues. Thus, the crystal structure of MtPth when compared with that of EcPth, leads to a model of structural changes associated with enzyme action on the basis of the plasticity of the molecule. A discrepancy between the X-ray results and NMR results, which subsequently became available, led to X-ray studies on new crystal forms of the enzyme. The results of these studies and those of the enzyme from different sources that became available, confirmed the connection deduced previously between the closure of the lid at the peptide-binding site and the opening of the gate that separates the peptide-binding site and tRNA binding site. The plasticity of the molecule indicated by X-ray structures is in general agreement with that deduced from the available solution NMR results. The correlation between the lid and the gate movement is not, however, observed in the NMR structure of MtPth. The discrepancy between the X-ray and NMR structures of MtPth in relation to the functionally important plasticity of the molecule, referred to earlier, also led to molecular dynamics simulations. The X-ray and the NMR studies along with the simulations indicated an inverse correlation between crowding and molecular volume. A detailed comparison of proteins for which X-ray and the NMR structures are available appears to confirm this correlation. In consonance with the reported results of the investigation in cellular components and aqueous solutions, the comparison indicates that the crowding results in compaction of the molecule as well as change in its shape, which could specifically involve regions of the molecule important for function. Crowding could thus influence the action of proteins through modulation of the functionally important plasticity of the molecule. After termination of protein synthesis at the stop codon, the ribosome remains as a post-termination complex (PoTC), consisting of the 30S and the 50S subunits, mRNA and a deacylated tRNA. This complex has to be disassembled so that the ribosome is available for the next round of translation initiation. Ribosome recycling factor (RRF) binds to ribosome and in concert with elongation factor G (EF.G), performs the recycling of ribosome that results in disassembly of PoTC. The structure of this L-shaped protein with two domains connected by a hinge, from Mycobacterium tuberculosis (MtRRF) was solved previously in our laboratory. The relative movement of domains lies at the heart of RRF function. Three salt bridges were hypothesized to reduce the flexibility of MtRRF when compared to the protein from E.coli (EcRRF), which has only one such salt bridge. Out of these three bridges, two are between domain 1 and domain 2, whereas the third is between the hinge region and the C-terminus of the molecule. These salt bridges were disrupted with appropriate mutations and the structure and activity of the mutants and their ability to complement EcRRF were explored. An inactive C-terminal deletion mutant of MtRRF was also studied. Major, but different, structural changes were observed in the C-terminal deletion mutant and the mutant involving the hinge region. Unlike the wild type protein and the other mutants, the hinge mutant complements EcRRF. This appears to result from the increased mobility of the domains in the mutant, as evidenced by the results of librational analysis. In addition to the work on PTH and RRF, the author was involved during the period of studentship in carrying out X-ray studies of crystalline complexes involving amino acids and carboxylic acids, which is described in the Appendix of the thesis. The complexes studied are that of tartaric acid with arginine and lysine.

L’asplénie ou l’absence de la rate peut être congénitale, c’est- à -dire absente dès la naissance, ou bien acquise, par exemple lors d’une opération après un accident. L’asplénie congénitale est le plus souvent associée à d’autres problèmes développementaux. En particulier l’asplénie congénitale est associée à des problèmes de développement du cœur, dans le cadre des syndromes d’hétérotaxie. Ces syndromes d’hétérotaxie sont caractérisés par des problèmes de latéralité droite-gauche. Ainsi une personne ayant deux parties ‘droites’ n’aura pas de rate. A contrario, l’asplénie congénitale isolée est caractérisée par l’absence de rate et aucune autre malformation. L’asplénie congénitale isolée est une maladie très rare. Nous avons estimé la fréquence de la maladie à un cas pour un million de naissances. C’est aussi une maladie extrêmement mortelle. La grande majorité des patients ayant une asplénie congénitale isolée souffrent d’infections bactériennes sévères lors de l’enfance et la moitie des cas reportés sont décédés dus à une infection bactérienne, le plus souvent du à une infection par Streptococcus pneumoniae. Malgré la sévérité de cette maladie, celle-ci reste très peu connue et très peu étudiée. Ainsi le diagnostique est souvent trop tardif. Parmi les quelques dizaines de cas décrits dans la littérature, la moitié sont des cas familiaux avec plusieurs membres de la même famille affectée. Le mode de transmission semble être autosomique dominant dans la majorité des cas. En outre aucune preuve n’existe concernant un facteur environnemental pour cette maladie. Enfin des travaux récents ont montrés que l’absence de pancréas chez l’homme était une maladie génétique, et due à des mutations dans le gène GATA6 chez la moitié des patients. L’objectif de cette thèse est donc de déterminer l’origine génétique de l’asplénie congénitale isolée chez l’homme. J’ai fait l’hypothèse que l’asplénie congénitale isolée chez l’homme est due à des mutations mendéliennes dans un gène important pour le développement de la rate. Afin de tester notre hypothèse nous avons recruté des patients à travers des collaborations avec des médecins étrangers ainsi qu’un partenariat avec toutes les unités pédiatriques de France. Nous avons finalement pu recruter 37 patients appartenant à 24 familles différentes. La littérature sur le développement de la rate chez la souris et encore plus sur l’homme étant minimale, il était difficile d’identifier de bons gènes candidats pour être responsables de l’asplénie. Nous avons donc opté pour une stratégie portant sur le génome entier, sans biais lier a la littérature. La stratégie était d’utiliser le séquençage de l’exome de tous les patients. Le séquençage de l’exome est en fait le séquençage de tous les exons du génome, ou au moins 90% des exons du génome. La technique du séquençage de l’exome est arrivée à la fin de l’année 2009 et nous avons été un des premiers laboratoires à l’utiliser. Il fallait donc que nous l’essayons en premier sur un cas facile afin de vérifier que cette technique fonctionnait. Nous avons donc fait une étude préliminaire sur un cas ‘facile’. Par cas facile, il faut comprendre un cas où la probabilité que ce soit une mutation mendélienne dans un gène qui soit responsable de la maladie soit la plus forte possible, et où le nombre de gènes à regarder soit le plus faible possible. Un cas ‘facile’ est donc le cas d’une famille avec de nombreux patients, et de surcroit une famille consanguine. Dans le cas d’une famille consanguine la probabilité que ce soit une mutation récessive qui soit responsable de la maladie génétique est très importante. On peut alors se restreindre à analyser les régions du génome ou toutes les variations sont homozygotes. Nous avions une famille dans ce cas. Il y avait 4 patients dans cette famille souffrant d’infections bactériennes sévères dues à une asplenie fonctionnelle, ainsi que d’infections virales / Isolated congenital asplenia (ICA) is a rare primary immunodeficiency, first described in 1956, thattypically manifests in childhood with sudden, life-threatening, invasive bacterial disease. Patients withICA do not display any other overt developmental anomalies. The genetic etiology of ICA has remainedelusive. I hypothesized that ICA results from single-gene inborn errors of spleen development. I aimedto decipher the molecular genetic basis of ICA by pursuing a genome-wide approach, based on thesequencing of the whole-exome and the detection of copy number variations in all patients of ourcohort. I found that heterozygous mutations in RPSA, ribosomal protein SA, were present in more thanhalf of ICA patients (19/33). I then showed that haploinsufficiency of RPSA led to ICA in one kindredat least. RPSA is a protein involved in pre-rRNA processing and is an integral part of the ribosome. Thechallenge is, now, to understand the pathogenesis of the disease. How does a mutation in a ubiquitousand highly expressed gene lead to a spleen specific phenotype? This discovery will set the basis for abroader understanding of the development of the spleen in humans and the function of a ribosomalprotein. This discovery will also be beneficial to the families of patients with ICA, guiding geneticcounseling. It will lead to prevention of infections in newborns with mutations in RPSA. Finally themethod we used to analyze the exomes of the ICA cohort will be useful to discover the genetic etiologyof other genetic diseases.

No description available.